Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway

Oncogene

Volumn 31, Issue 9, 2012, Pages 1189-1195

  Visser Grieve, S ^a   Hao, Y ^a   Yang, X ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

expanded; FRMD6; Hippo; LATS1; tumor suppressor; Willin

Indexed keywords

CYCLIN A; PACLITAXEL; PROTEIN HEX; PROTEIN LATS1; PROTEIN LATS2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DROSOPHILA; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETAL PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PACLITAXEL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA; MUS MUSCULUS;

EID: 84857784575     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.318     Document Type: Article

References (37)

1. Badouel C, Gardano L, Amin N, Garg A, Rosenfeld R, Le Bihan T et al. (2009). The FERM-domain protein expanded regulates hippo pathway activity via direct interactions with the transcriptional activator yorkie. Dev Cell 16: 411-420.
2. Blaumueller CM, Mlodzik M. (2000). The drosophila tumor suppressor expanded regulates growth, apoptosis, and patterning during development. Mech Dev 92: 251-262.
3. Boedigheimer M, Laughon A. (1993). Expanded: a gene involved in the control of cell proliferation in imaginal discs. Development 118: 1291-1301.
4. Boedigheimer MJ, Nguyen KP, Bryant PJ. (1997). Expanded functions in the apical cell domain to regulate the growth rate of imaginal discs. Dev Genet 20: 103-110.
5. Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH. (2005). The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24: 2076-2086.
6. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W et al. (2008). A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598.
7. Feng Y, Irvine KD. (2007). Fat and expanded act in parallel to regulate growth through warts. Proc Natl Acad Sci USA 104: 20362-20367.
8. Genevet A, Wehr MC, Brain R, Thompson BJ, Tapon N. (2010). Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 18: 300-308.
9. Gunn-Moore FJ,Welsh GI, Herron LR, Brannigan F, Venkateswarlu K, Gillespie S et al. (2005). A novel 4.1 ezrin radixin moesin (FERM)-containing protein, 'willin'. FEBS Lett 579: 5089-5094.
10. Guo C, Tommasi S, Liu L, Yee JK, Dammann R, Pfeifer GP. (2007). RASSF1A is part of a complex similar to the drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr Biol 17: 700-705.
11. Halder G, Johnson RL. (2011). Hippo signaling: growth control and beyond. Development 138: 9-22.
12. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C et al. (2006). The tumour-suppressor genes NF2/Merlin and expanded act through hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 8: 27-36.
13. Hanahan D, Weinberg RA. (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
14. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. (2008). Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496-5509.
15. Jung YS, Qian Y, Chen X. (2010). Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 22: 1003-1012.
16. Lai D, Ho KC, Hao Y, Yang X. (2011). Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res 71: 2728-2738.
17. Lau YK, Murray LB, Houshmandi SS, Xu Y, Gutmann DH, Yu Q. (2008). Merlin is a potent inhibitor of glioma growth. Cancer Res 68: 5733-5742.
18. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. (2008). TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436.
19. Li W, Wang L, Katoh H, Liu R, Zheng P, Liu Y. (2011). Identification of a tumor suppressor relay between the FOXP3 and the hippo pathways in breast and prostate cancers. Cancer Res 71: 2162-2171.
20. Li Y, Pei J, Xia H, Ke H, Wang H, Tao W. (2003). Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22: 4398-4405.
21. McCartney BM, Kulikauskas RM, LaJeunesse DR, Fehon RG. (2000). The neurofibromatosis-2 homologue, merlin, and the tumor suppressor expanded function together in drosophila to regulate cell proliferation and differentiation. Development 127: 1315-1324.
22. McGrogan BT, Gilmartin B, Carney DN, McCann A. (2008). Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 1785: 96-132.
23. Ogryzko VV, Wong P, Howard BH. (1997). WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol 17: 4877-4882.
24. Ota M, Sasaki H. (2008). Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of hippo signaling. Development 135: 4059-4069.
25. Pan D. (2010). The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
26. Pellock BJ, Buff E, White K, Hariharan IK. (2007). The drosophila tumor suppressors expanded and merlin differentially regulate cell cycle exit, apoptosis, and wingless signaling. Dev Biol 304: 102-115.
27. Polesello C, Huelsmann S, Brown NH, Tapon N. (2006). The drosophila RASSF homolog antagonizes the hippo pathway. Curr Biol 16: 2459-2465.
28. Radu M, Chernoff J. (2009). The DeMSTification of mammalian Ste20 kinases. Curr Biol 19: R421-R425.
29. Stern C, Bridges CB. (1926). The mutants of the extreme left end of the second chromosome of DROSOPHILA MELANOGASTER. Genetics 11: 503-530.
30. Visser S, Yang X. (2010a). Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray. Gene 449: 22-29.
31. Visser S, Yang X. (2010b). LATS tumor suppressor: a new governor of cellular homeostasis. Cell Cycle 9: 3892-3903.
32. Xia H, Qi H, Li Y, Pei J, Barton J, Blackstad M et al. (2002). LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21: 1233-1241.
33. Xiao L, Chen Y, Ji M, Dong J. (2011). KIBRA regulates hippo signaling activity via interactions with large tumor suppressor kinases. J Biol Chem 286: 7788-7796.
34. Yang X, Li DM, Chen W, Xu T. (2001). Human homologue of drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene 20: 6516-6523.
35. Yu J, Zheng Y, Dong J, Klusza S, Deng WM, Pan D. (2010). Kibra functions as a tumor suppressor protein that regulates hippo signaling in conjunction with merlin and expanded. Dev Cell 18: 288-299.
36. Zhao B, Li L, Lei Q, Guan KL. (2010). The hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24: 862-874.
37. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. (2008). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.